Singh Kalpana, Joy George V, Al Bulushi Asma, Alomari Albara Mohammad Ali, Mannethodi Kamaruddeen, Kunjavara Jibin, Hassan Nesiya, Idris Zeinab, Yassin Mohd Abdel Daem Mohd, Al Lenjawi Badriya
Nursing & Midwifery Research Department, Hamad Medical Corporation, Doha, Qatar.
National Centre for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
Glob Epidemiol. 2025 Jan 9;9:100184. doi: 10.1016/j.gloepi.2025.100184. eCollection 2025 Jun.
Multimorbidity in adult patients puts them at a considerable risk of not taking their medications as prescribed. It is well known that patients with chronic conditions with self-management help is an excellent way to improve medication compliance. The impact of the medication self-management intervention in adult patients with multimorbidity is not well known, yet. This paper presents the protocol to assess the efficacy of a nurse-led medication self-management intervention in enhancing medication adherence and health outcomes for adult patients with multimorbidity.
The Standard Protocol Items: Guidelines for Interventional Trials 2013 statement is followed by the study protocol. This study is a two-arm, single centre, open label, randomized controlled trial. Adult patients with multimorbidity will be recruited from National Cancer Center Research, QATAR. A total of 100 participants will be randomly assigned to either standard care alone or standard care along with the medication self-management intervention. Clinical nursing specialists will deliver the intervention. Three in-person education sessions and two weekly phone conversations for follow-up are part of the 6-week intervention. Participants in the control group continue to receive all aspects of the standard care provided by healthcare professionals, including consultations regarding patients' diseases and treatments, management of chronic conditions, prescription of medications, referrals to hospital specialists, health education, and management of chronic conditions.The 8-item mo-risky-8 Medication Adherence Scale was used to measure medication adherence as the primary outcome. Secondary outcomes include medication self-management capacity (medication knowledge, medication beliefs, and medication self-efficacy), treatment experiences (medication treatment satisfaction and treatment burden), and depressive symptoms. All outcomes will be assessed at baseline, immediately post-intervention, and at 3-month post-intervention.
This study will offer proof of the merits of a nurse-delivered medication self-management intervention for adult patients with multimorbidity and adherence issues. If the study findings are helpful in enhancing patient adherence and health outcomes, it is anticipated that they will offer healthcare professionals evidence-based self-management support tools for routine chronic condition management. The trial is registered at clinicaltrial.org (NCT05645653;9Dec2022).
成年患者的多种疾病使其面临不按医嘱服药的重大风险。众所周知,为慢性病患者提供自我管理帮助是提高药物依从性的绝佳方法。然而,药物自我管理干预对患有多种疾病的成年患者的影响尚不明确。本文介绍了一项评估由护士主导的药物自我管理干预对提高患有多种疾病的成年患者药物依从性和健康结局有效性的方案。
本研究方案遵循《干预性试验标准方案条目:2013年声明》。本研究是一项双臂、单中心、开放标签的随机对照试验。患有多种疾病的成年患者将从卡塔尔国家癌症中心研究招募。总共100名参与者将被随机分配到仅接受标准护理或接受标准护理并同时接受药物自我管理干预。临床护理专家将实施干预。为期6周的干预包括三次面对面教育课程和两次每周的随访电话交谈。对照组的参与者继续接受医疗保健专业人员提供的标准护理的所有方面,包括关于患者疾病和治疗的咨询、慢性病管理、药物处方、转诊至医院专科医生、健康教育以及慢性病管理。使用8项的“低风险-8药物依从性量表”来测量药物依从性作为主要结局。次要结局包括药物自我管理能力(药物知识、药物信念和药物自我效能)、治疗体验(药物治疗满意度和治疗负担)以及抑郁症状。所有结局将在基线、干预后立即以及干预后3个月进行评估。
本研究将为护士提供的药物自我管理干预对患有多种疾病和依从性问题的成年患者的益处提供证据。如果研究结果有助于提高患者依从性和健康结局,预计它们将为医疗保健专业人员提供基于证据的自我管理支持工具,用于常规慢性病管理。该试验已在clinicaltrial.org注册(NCT05645653;2022年12月9日)。